mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.03 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |